These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3929295)

  • 1. Kinetics of citalopram in elderly patients.
    Fredericson Overø K; Toft B; Christophersen L; Gylding-Sabroe JP
    Psychopharmacology (Berl); 1985; 86(3):253-7. PubMed ID: 3929295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary studies of the kinetics of citalopram in man.
    Overø KF
    Eur J Clin Pharmacol; 1978 Nov; 14(1):69-73. PubMed ID: 729609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels.
    Bjerkenstedt L; Flyckt L; Overø KF; Lingjaerde O
    Eur J Clin Pharmacol; 1985; 28(5):553-7. PubMed ID: 3899675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinetics of citalopram: single and multiple dose studies in man.
    Kragh-Sørensen P; Overø KF; Petersen OL; Jensen K; Parnas W
    Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):53-60. PubMed ID: 6939299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of citalopram in the blood serum and in the central nervous system of rats after single and multiple dosage.
    Melzacka M; Rurak A; Adamus A; Daniel W
    Pol J Pharmacol Pharm; 1984; 36(6):675-82. PubMed ID: 6598490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of citalopram in man; plasma levels in patients.
    Fredricson Overø K
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):311-8. PubMed ID: 6959195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram.
    Hyttel J; Overø KF; Arnt J
    Psychopharmacology (Berl); 1984; 83(1):20-7. PubMed ID: 6429698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171).
    Gottlieb P; Wandall T; Overø KF
    Acta Psychiatr Scand; 1980 Sep; 62(3):236-44. PubMed ID: 6935914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study.
    Pedersen OL; Kragh-Sørensen P; Bjerre M; Overø KF; Gram LF
    Psychopharmacology (Berl); 1982; 77(3):199-204. PubMed ID: 6812140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of citalopram in test animals; drug exposure in safety studies.
    Fredricson Overø K
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):297-309. PubMed ID: 6959194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citalopram--a specific 5-HT-reuptake inhibitor--as an antidepressant drug: a phase II multicentre trail.
    Ofsti E
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):327-35. PubMed ID: 6959197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
    Arnt J; Hyttel J; Overø KF
    Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citalopram--a highly selective 5-HT uptake inhibitor--in the treatment of depressed patients.
    Dufour H; Bouchacourt M; Thermoz P; Viala A; Phak Rop P; Gouezo F; Durand A; Høpfner Petersen HE
    Int Clin Psychopharmacol; 1987 Jul; 2(3):225-37. PubMed ID: 3320186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Open preliminary study of new antidepressive compound: citalopram].
    Ropert R; Lôo H; Gay C
    Encephale; 1984; 10(3):131-4. PubMed ID: 6594229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serotonin uptake inhibitor citalopram attenuates ethanol intake.
    Naranjo CA; Sellers EM; Sullivan JT; Woodley DV; Kadlec K; Sykora K
    Clin Pharmacol Ther; 1987 Mar; 41(3):266-74. PubMed ID: 3469057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary studies with citalopram (LU 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant.
    Gastpar M; Gastpar G
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):319-25. PubMed ID: 6959196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]citalopram binding to brain and platelet membranes of human and rat.
    Plenge P; Mellerup ET
    J Neurochem; 1991 Jan; 56(1):248-52. PubMed ID: 1824783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
    Arnt J; Overø KF; Hyttel J; Olsen R
    Psychopharmacology (Berl); 1984; 84(4):457-65. PubMed ID: 6441945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthostatic side effects of clomipramine and citalopram during treatment for depression.
    Christensen P; Thomsen HY; Pedersen OL; Gram LF; Kragh-Sørensen P
    Psychopharmacology (Berl); 1985; 86(4):383-5. PubMed ID: 3929308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective disposition of mexiletine in man.
    Grech-Belanger O; Turgeon J; Gilbert M
    Br J Clin Pharmacol; 1986 May; 21(5):481-7. PubMed ID: 3718807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.